We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE)

Shenzhen New Industries Biomedical Engineering Co., Ltd. (SNIBE) is a biotechnology company specializing in clinical ... read more Featured Products: More products

Download Mobile App




New biochemistry analyzer helps labs realize full automation and maximum efficiency

By LabMedica International staff writers
Posted on 26 May 2022
Print article
Image: Biossays C8 automatic biochemistry analyzer (Photo courtesy of SNIBE)
Image: Biossays C8 automatic biochemistry analyzer (Photo courtesy of SNIBE)

Snibe (Shenzhen, China) has launched the new Biossays C8 automatic biochemistry analyzer, marking the beginning of a new journey in clinical chemistry management. Its powerful performance and modular scalability enables labs to realize full automation and maximum efficiency.

The Biossays C8 automatic biochemistry analyzer has a high throughput of 1600 tests per hour (single module) and 6400 tests per hour (four modules combined). It has two reagent compartments with 72 positions each and a total of 300 sample positions. The precise control of temperature and voltage of light source lamp guarantee minor fluctuation of the light source and long life of the lamp. It has a configurable decapper module that can improve lab efficiency with no manual operation required of the sample tubes. It allows for full mixing with adjustable speed and the mixing speed of different reagents can be set independently.

The Biossays C8 also enables complete washing with less wash liquid required, automatic selection of acid and alkali liquid (assay dependent) and double washing of each mixing bar. The ISE module for five common ions is also configurable according to individual needs. The Biossays C8 can be linked with Laboratory Automation system (TLA/LAS) and create a random combination within four units according to testing demand. It is capable of integrating the immunoassay analyze MAGLUMI X8, which perfectly realizes the function of TLA but only takes up a small space in the lab.

Related Links:
Snibe

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Ultra-Low Temperature Freezer
iUF118-GX
New
Calprotectin Assay
Fecal Calprotectin ELISA

Print article

Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.